🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking fines, legal action or prison.

Platform Reaction and Material Removal

Based on the social media company, the service has taken down violative content and banned associated hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of users, filled with images of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

After minutes of entering one group, a vendor posted contact information, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Product Details and Costs

Inside these communities, messages show dark colored parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.